Please login to the form below
New president for Spanish Society of Pharmacology
Maria Jesús Sanz is a professor of pharmacology at the University of Valencia
The Spanish Society of Pharmacology (SEF) has named Maria Jesús Sanz as its new president.
Jesús Sanz, a professor of pharmacology at the University of Valencia, was elected to the role at the Society's annual meeting in Madrid. He replaces Teresa Tejerina.
Jesús Sanz has over 25 years' experience as a teacher and researcher and has studied in the UK and Canada. His research focuses on the study of inflammatory processes, mediators, leukocyte-endothelium interactions and leukocyte infiltration in various pathologies.
In his new role Jesús Sanz will lead the SEF in its mission to become a forum for people in Spain who are interested in pharmacology and medicine. He will also promote international relations for Spanish researchers and work to improve the Society's relationship with the pharma industry.
Featured jobs
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
- Account Director, Healthcare Communications
-
Salary TBC
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
Subscribe to our email news alerts
- GSK hires Merck KGaA exec to lead US pharma business
- Novartis chooses internal replacement for US pharma president role
- Moving annual total (MAT)
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Novartis chooses internal replacement for US pharma president role
- Lilly psoriasis drug beats J&J's Tremfya in head-to-head trial
- A uniquely English genomic medicine service
- FDA rejects Sarepta’s new Duchenne drug over safety fears
- AZ claims first-in-class win for Farxiga in heart failure
- UK no longer measles-free as vaccination rates fall dramatically
- Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO
- Blended Intelligence
PMHub
Real Science Communications
Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...
Latest intelligence
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
Quick links
Infographics
